Novartis Investigative Site
Stellenbosch, Western Cape 7600
0 studies enrolling now · 3 studies all time
What they study most
Autoimmunity, Inflammation, Polymyalgia Rheumatica, Sjogren Syndrome
Studies at this site
- Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
- Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed
- Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome — Running, not enrolling